GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
78 hedge funds and large institutions have $42.3M invested in GALENA BIOPHARMA INC COM in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 15 closing their positions.
41% more call options, than puts
Call options by funds: $5.1M | Put options by funds: $3.63M
9% less funds holding
Funds holding: 86 → 78 (-8)
11% less capital invested
Capital invested by funds: $47.5M → $42.3M (-$5.18M)
12% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 25
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$898K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$615K |
| 3 |
State Street
Boston,
Massachusetts
|
+$196K |
| 4 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
+$79.9K |
| 5 |
HF
Hoxton Financial
Shepherdstown,
West Virginia
|
+$47.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.38M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$370K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$366K |
| 4 |
Bank of New York Mellon
New York
|
-$143K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$126K |
RXII Hedge Fund Activity: Q3 2015 in Review
78 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q3 2015, worth a combined $42.3M — down 11% from $47.5M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of RXII and 7 opened new positions — a net loss of 8 holders — while 25 trimmed existing stakes and 22 added.
The largest buyer was Group One Trading, adding an estimated $898K. The largest seller was Highland Capital Management (Texas), exiting entirely with an estimated $2.38M sold.
- 78 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q3 2015, down from 86 in Q2 2015.
- Funds reported $42.3M of GALENA BIOPHARMA INC COM stock for Q3 2015, down 11% quarter-over-quarter.
- 7 funds opened new GALENA BIOPHARMA INC COM positions in Q3 2015 and 15 closed out, a net change of -8 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q3 2015 was Group One Trading, an estimated $898K added.
- The largest GALENA BIOPHARMA INC COM seller in Q3 2015 was Highland Capital Management (Texas), an estimated $2.38M sold.
Based on aggregated 13F filings for Q3 2015.